In this section you will find Selcia news and up-coming events Selcia is attending.
News & Events
Selcia Limited and Swedish drug development company NeuroVive Pharmaceutical AB have signed a significant research collaboration agreement to develop new medicines and drug compounds targeting mitochondrial physiology and pathophysiology
In response to an ever-growing US client base, Selcia today announced the opening of their new SelciaWest facility, in Hopkinton MA (USA).
Labelling molecules with carbon-14 allows them to be detected in situ, providing an essential tool for determining the behaviour and fate of chemical compounds in organisms and in the environment.
Simon has over 30 years of commercial experience within the life sciences industry, and brings with him a strong mix of technical, strategic and business development expertise.
Selcia Ltd today announced the successful completion of a drug discovery project with ExonHit Therapeutics SA (Paris, France), using Selcia’s fragment screening technology.